Commit To Buy SciClone Pharmaceuticals At $7.50, Earn 10.2% Annualized Using Options
March 16, 2015 at 11:37 AM EDT
Investors considering a purchase of SciClone Pharmaceuticals, Inc. (SCLN) stock, but cautious about paying the going market price of $8.92/share, might benefit from considering selling puts among the alternative strategies at their disposal..